Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

NCT02705300 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Irinotecan 165 mg/m2 iv
DRUG: Oxaliplatin 85 mg/m2 iv
DRUG: Calcium folinate 200 mg/m2 iv
DRUG: 5-fluorouracil 3200 mg/m2
DIETARY_SUPPLEMENT: Tocotrienol
DRUG: Placebo

Sponsor

Vejle Hospital